References
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
- FockKMReview article: the epidemiology and prevention of gastric cancerAliment Pharmacol Ther201440325026024912650
- ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
- ThieryJPSleemanJPComplex networks orchestrate epithelial-mesenchymal transitionsNat Rev Mol Cell Biol20067213114216493418
- KongDLiYWangZSarkarFHCancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?Cancers20113171672921643534
- Prieto-GarcíaEDíaz-GarcíaCVGarcía-RuizIAgulló-OrtuñoMTEpithelial-to-mesenchymal transition in tumor progressionMed Oncol20173412228560682
- Benham-PyleBWPruittBLNelsonWJCell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entryScience201534862381024102726023140
- PittiRMMarstersSALawrenceDAGenomic amplification of a decoy receptor for Fas ligand in lung and colon cancerNature199839667126997039872321
- YuKYKwonBNiJZhaiYEbnerRKwonBSA newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosisJ Biol Chem199927420137331373610318773
- MigoneTSZhangJLuoXTL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulatorImmunity200216347949211911831
- LinWWHsiehSLDecoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancerBiochem Pharmacol201181783884721295012
- LiuYPZhuHFLiuDLDcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRCOncotarget2016747773067731827764793
- ZhangHChenXLiDDcR3 promotes hepatoma cell migration by downregulating E-cadherin expressionOncol Rep201738137738328560426
- WuYGuoEYuJXieQHigh DcR3 expression predicts stage pN2-3 in gastric cancerAm J Clin Oncol2008311798318376232
- LiangQLWangBRLiGHGhLDcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parametersJ Zhejiang Univ Sci B200910967568219735100
- ChenCZhangCZhuangGDecoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) developmentCancer Invest2008261096597419093253
- WuQZhengYChenDLiXLuCZhangZAberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesisJ Surg Res2014188245946524612949
- YamanaKBilimVHaraNPrognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progressionBr J Cancer200593554455116091761
- TongJAoRWangYChangBWangBYPrognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysisInt J Clin Exp Med2014793096310525356187
- JiangMLinXHeRDecoy receptor 3 (DcR3) as a biomarker of tumor deterioration in female reproductive cancers: a meta-analysisMed Sci Monit2016221850185727246752
- GeHLiangCRenSYueCWuJPrognostic value of DcR3 in solid tumors: a meta-analysisClin Chim Acta201848112613129499202
- YuWXuYCTaoYDcR3 regulates the growth and metastatic potential of SW480 colon cancer cellsOncol Rep20133062741274824101127
- ZhouXNLiGMXuYCZhaoTJWuJXKnockdown of decoy receptor 3 impairs growth and invasiveness of hepatocellular carcinoma cell line of HepG2Chin Med J2016129212623262927779171
- LiangCXuYLiGDownregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosisOnco Targets Ther20171041742828176915
- ArveloFSojoFCotteCTumour progression and metastasisEcancermedicalscience20161061726913068
- ThompsonEWNewgreenDFTarinDCarcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?Cancer Res200565145991599516024595
- MacdonaldBTTamaiKHeXWnt/beta-catenin signaling: components, mechanisms, and diseasesDev Cell200917192619619488
- MartiniMde SantisMCBracciniLGulluniFHirschEPI3K/AKT signaling pathway and cancer: an updated reviewAnn Med201446637238324897931
- ZhangYHuangSLengYEffect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKTOnco Targets Ther201695195520227621648
- TodaMKawamotoTUehaT‘Decoy’ and ‘non-decoy’ functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cellsInt J Oncol201343370371223817777
- ChenPHYangCRDecoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathwayJ Immunol2008181128441844919050262
- HoCHHsuCFFongPFEpstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoterJ Virol20078194837484717301127